-検索条件
-検索結果
検索 (著者・登録者: pellanda & m)の結果全36件を表示しています
EMDB-29530:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
EMDB-29531:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
EMDB-40240:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
PDB-8fxb:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
PDB-8fxc:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
PDB-8s9g:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
EMDB-27177:
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
PDB-8d48:
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
EMDB-24236:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
EMDB-24237:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
PDB-7n8h:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement
PDB-7n8i:
SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20)
EMDB-22491:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
EMDB-22492:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
EMDB-22494:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
EMDB-22497:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
EMDB-22506:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
EMDB-22507:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (two receptor-binding domains open)
EMDB-22508:
SARS-CoV-2 spike in complex with the S2H14 neutralizing antibody Fab fragment (three receptor-binding domains open)
EMDB-22512:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
EMDB-22516:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment
EMDB-22517:
SARS-CoV-2 spike in complex with the S2X35 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
PDB-7jv2:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of the receptor-binding motif and Fab variable domains)
PDB-7jv4:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open)
PDB-7jv6:
SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation)
PDB-7jva:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)
PDB-7jvc:
SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment
PDB-7jw0:
SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment
EMDB-3005:
Cytoplasmic ring of the native X. laevis nuclear pore complex.
EMDB-3006:
Spoke ring and central channel ring of the native X. laevis nuclear pore complex.
EMDB-3007:
Nucleoplasmic ring of the native X. laevis nuclear pore complex.
EMDB-3008:
Nuclear envelope of the native X. laevis nuclear pore complex.
EMDB-3009:
Cytoplasmic ring of the actinomycin D treated X. laevis nuclear pore complex.
EMDB-3010:
Spoke ring and central channel ring of the actinomycin D treated X. laevis nuclear pore complex.
EMDB-3011:
Nucleoplasmic ring of the actinomycin D treated X. laevis nuclear pore complex.
EMDB-3012:
Nuclear envelope of the actinomycin D treated X. laevis nuclear pore complex.